Loading...
XHKG
2877
Market cap725mUSD
Jul 10, Last price  
7.67HKD
1D
1.86%
1Q
-22.84%
Jan 2017
-12.84%
IPO
63.19%
Name

China Shineway Pharmaceutical Group Ltd

Chart & Performance

D1W1MN
XHKG:2877 chart
P/E
5.28
P/S
1.60
EPS
1.26
Div Yield, %
6.71%
Shrs. gr., 5y
-0.04%
Rev. gr., 5y
3.38%
Revenues
3.14b
-17.01%
841,475,0001,012,885,0001,275,179,0001,633,223,0002,038,379,0001,984,542,0002,132,249,0002,187,115,0002,229,201,0002,054,809,0001,993,379,0001,919,608,0002,570,196,0002,705,996,0002,655,701,0003,223,550,0003,950,636,0004,516,538,0003,778,043,0003,135,419,000
Net income
950m
+13.08%
332,977,000490,641,000398,242,000767,304,000821,756,000755,600,000647,704,000683,647,000704,775,000657,906,000589,196,000451,553,000505,876,000503,150,000295,033,000556,674,000722,773,000969,510,000840,052,000949,948,000
CFO
1.17b
+21.69%
417,409,000401,970,000405,280,0001,057,320,000579,425,000485,062,000635,673,000519,886,000773,158,000744,707,000733,526,000490,646,000532,586,000367,996,000638,566,000703,150,0001,109,676,000932,635,000963,135,0001,172,033,000
Dividend
Sep 09, 20250.12 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

As an investment holding company, China Shineway Pharmaceutical Group Limited primarily focuses on the research, development, production, and commercialization of traditional Chinese medicines across mainland China and Hong Kong. Its product portfolio encompasses contemporary Chinese medicines delivered as soft capsules, granules, and injectable solutions. Additionally, it provides specialized TCM Formula Granules, addressing a broad spectrum of medical conditions such as cardiovascular and cerebrovascular issues, viral infections, orthopedic complaints, pediatric ailments, gynecological disorders, and gastrointestinal problems. Beyond pharmaceuticals, the group also engages in the trading of agricultural commodities. Established in 2004, China Shineway Pharmaceutical Group Limited maintains its corporate headquarters in Shijiazhuang, within the People's Republic of China. The company operates as a subsidiary under the umbrella of Forway Investment Limited.
URL
http://www.shineway.com.hk
IPO date
Dec 02, 2004
Employees
4,131
Domiciled in
CN
Incorporated in
KY

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT